Photo by nci from unsplash
The survival benefit of surgical (SAVR) or transcatheter (TAVR) aortic valve replacement over conservative management remains unclear in patients with low-flow, low-gradient (LFLG) aortic stenosis (AS). The TOPAS study prospectively… Click to show full abstract
The survival benefit of surgical (SAVR) or transcatheter (TAVR) aortic valve replacement over conservative management remains unclear in patients with low-flow, low-gradient (LFLG) aortic stenosis (AS). The TOPAS study prospectively recruited 476 LFLG severe AS patients (mean age 75±10 yo, 71%
Keywords:
patients low;
low gradient;
aortic stenosis;
flow low;
low flow
Journal Title: Journal of the American College of Cardiology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!